Fundz

Xenocor Completes Oversubscribed $10 Million Series A To Lead The Future Of Laparoscopic Visualization

PRIVATEApr 18, 2023

Amount Raised

$10 Million

Round Type

Series A

Salt Lake CityHealthcare

Investors

Gen Henn CapitalXenocorPatel Family InvestmentsBarvest VenturesBaranco InvestmentsGen Henn Venture Fund I

Description

Xenocor, creator of the FDA cleared Saberscope, the world's first true HD, fog-free, articulating, single-use laparoscope, announced a $10 million Series A funding led by GenHenn Venture Fund I with participation from Baranco Investments, Inc., Barvest Ventures, Inc. and Patel Family Investments. Xenocor will use the capital for the 2023 launch of the Saberscope and to continue executing on its robust innovation roadmap. To help accelerate the company's growth, Michael J

Quick answer

Xenocor raised $10 Million in a Series A round, dated April 18, 2023. Investors: Gen Henn Capital, Xenocor, Patel Family Investments, Barvest Ventures, Baranco Investments and Gen Henn Venture Fund I. Xenocor is based in Salt Lake City, Utah, United States.

How much did Xenocor raise?
Xenocor raised $10 Million in a Series A round on April 18, 2023.
Who invested in Xenocor?
Gen Henn Capital, Xenocor, Patel Family Investments, Barvest Ventures, Baranco Investments and Gen Henn Venture Fund I are named as investors in this round.
What does Xenocor do?
Xenocor is actively solving challenges in minimally invasive surgery by bringing the Saberscope single-use, fog-free, articulating laparoscopic platform to market.
Where is Xenocor based and how big is it?
Xenocor is based in Salt Lake City, Utah, United States.
Who are the decision-makers at Xenocor?
Fundz holds 2 contacts at Xenocor, including the Director of Sales - West. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Xenocor that raised within 45 days of this round, from Fundz verified event records.

  • Hummingbird Healthcare raised $1.2M (Seed) on May 9, 2023.
  • Cambrian BioPharma raised $7.7M on June 2, 2023.
  • Phio Pharmaceuticals raised $3M (Seed) on June 2, 2023.
  • Crio Inc. raised $1.8M (Series B) on June 2, 2023.
  • Steel Therapeutics raised $3M (Seed) on June 1, 2023.
  • EpiWatch, Inc. raised $340K (Seed) on June 1, 2023.

Who to call at Xenocor, and when

A new round usually means Xenocor is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Xenocor raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xenocor, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xenocor. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xenocor

Location

630 KOMAS DR.

Salt Lake City, Utah, United States

About

Xenocor is actively solving challenges in minimally invasive surgery by bringing the Saberscope single-use, fog-free, articulating laparoscopic platform to market. Xenocor is a privately held corporation, based in Salt Lake City, UT. Learn more at: www.saberscope.com/resources

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xenocor raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsManny, Director of Sales - WestSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Xenocor's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Xenocor raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.